Position in KYMR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$57,434,533
+$40,477,939 QoQ
Shares Held
500,868
+146.0% QoQ
Ownership
0.602%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#32
of 273 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. KYMR ranks #23 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,500,673 | $88,498,817 |
All Filings in KYMR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $57,434,533 | 500,868 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $16,956,594 | 203,585 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,840,948 | 203,585 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,036,800 | 248,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $21,737,564 | 498,111 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $14,375,955 | 525,245 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $21,620,728 | 537,428 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $24,852,699 | 525,094 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $15,456,240 | 517,797 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $20,137,386 | 500,930 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,565,120 | 100,751 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,434,327 | 103,189 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,500,875 | 108,781 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,963,296 | 100,010 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,496,000 | 100,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,177,000 | 100,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,969,000 | 100,000 | Shares | Sole | 2022-08-15 | |
| 2021-09-30 | $7,596,902 | 129,331 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,831,311 | 37,759 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $10,520,594 | 169,687 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $5,370,471 | 166,217 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||